Work

Results from phase 2 registration trial of SL-401 in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): Lead-in completed, expansion stage ongoing.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.7006

Authors: Naveen Pemmaraju, Andrew A. Lane, Kendra Lynn Sweet, Anthony Selwyn Stein, Sumithira Vasu, William G. Blum, David Rizzieri, Eunice S. Wang, Madeleine Duvic, Janice Chen, Shay Shemesh, Peter McDonald, Christopher Brooks, Hagop M. Kantarjian, Marina Konopleva

Institutions: The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute, Moffitt Cancer Center, City Of Hope National Medical Center, The Ohio State University Wexner Medical Center, Duke Medical Center, Roswell Park Comprehensive Cancer Center, Stemline Therapeutics (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2553684262

Cites:

Cited by: 13

Related to: 10